Stakeholders Give FDA An Earful; Poor Communication, Recall Inefficiency, Patients At Risk
Executive Summary
During a recent listening session on modernizing its recall process, the US FDA heard from industry, consumers, and patients — all of whom expressed a common theme: the agency needs to up its game in how it handles recalls.
You may also be interested in...
Lawmakers Want To Improve Medical Device Recalls By Improving How The FDA Communicates
Legislation introduced in both houses of Congress would improve how the FDA handles medical device recalls by requiring the agency to establish an electronic format to streamline communication among stakeholders.
MDIC Quality Summit Unveils New Risk-Based Framework, ‘Safe Space’ Recall Initiative
During a recent summit, the Medical Device Innovation Consortium Case for Quality Collaborative Community introduced a new risk-based CAPA framework that moves away from the current compliance-focused “one-size-fits-all” approach to a more comprehensive strategy. The summit also discussed how the industry can more effectively and quickly notify consumers about recalls.
More Cancer Cases Tied To Breast Implants, FDA Says
The US agency announced this week that it’s reviewing multiple reports of a form of carcinoma that arises in the scar tissue around a breast implant.